Unknown

Dataset Information

0

MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer.


ABSTRACT: MicroRNAs (miRNAs) present frequently altered expression in urologic cancers including prostate, bladder, and kidney cancer. The altered expression of miR-223 has been reported in cancers and other diseases in recent researches. MiR-223 is up-regulated in systemic lupus erythematosus and rheumatoid arthritis. In neoplastic diseases, miR-223 is proved to be up-expressed in plasma or serum and cancer tissues compared with normal tissues in pancreatic cancer, gastric cancer, et al. However, whether altered expression of miR-223 is associated with prostate cancer (PCa) and what it is potential functions in PCa remained unveiled. In this study, we firstly found miR-223-3p were up-regulated in prostate cancer tissues and then we study functional role of miR-223-3p in PCa using DU145, PC3 and LNCaP cell lines. Our data suggested that miR-223-3p might target gene SEPT6 and promoted the biological behavior of prostate cancer. Notably, we found increasing SEPT6 expression might reverse the biological activity induced by miR-223-3p, which might be a potential therapeutic target for PCa.

SUBMITTER: Wei Y 

PROVIDER: S-EPMC4269886 | biostudies-other | 2014

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC7426630 | biostudies-literature
| S-EPMC8222966 | biostudies-literature
| S-EPMC7447644 | biostudies-literature
| S-EPMC6667785 | biostudies-literature
| S-EPMC5993963 | biostudies-literature
| S-EPMC10486764 | biostudies-literature
| S-EPMC6933405 | biostudies-literature
| S-EPMC5732823 | biostudies-literature
| S-EPMC7031989 | biostudies-literature
| S-EPMC11311375 | biostudies-literature